Ani Pharmaceuticals (ANIP) Return on Capital Employed Growth (3y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 1,003.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,003.00 |
| Mar 31, 2026 | 1,136.00 |
| Dec 31, 2025 | 1,512.00 |
| Sep 30, 2025 | 1,568.00 |
| Jun 30, 2025 | 1,052.00 |
| Mar 31, 2025 | 974.00 |
| Dec 31, 2024 | 751.00 |
| Sep 30, 2024 | 531.00 |
| Jun 30, 2024 | 890.00 |
| Mar 31, 2024 | 878.00 |
| Dec 31, 2023 | 1,043.00 |
| Sep 30, 2023 | 1,110.00 |
| Jun 30, 2023 | 695.00 |
| Mar 31, 2023 | -203.00 |
| Dec 31, 2022 | -957.00 |
| Sep 30, 2022 | -2,071.00 |
| Jun 30, 2022 | -2,199.00 |
| Mar 31, 2022 | -2,156.00 |
| Dec 31, 2021 | -2,058.00 |
| Sep 30, 2021 | -1,216.00 |